Cargando…

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia

Adoptive cell therapy utilizing ex vivo expanded polyclonal CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) is in use in clinical trials for the treatment of type 1 diabetes and prevention of graft versus host disease in bone marrow transplantation. Here, we seek to evaluate this approach in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Debalina, Biswas, Moanaro, Liao, Gongxian, Seay, Howard R, Perrin, George Q, Markusic, David M, Hoffman, Brad E, Brusko, Todd M, Terhorst, Cox, Herzog, Roland W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213815/ https://www.ncbi.nlm.nih.gov/pubmed/25364772 http://dx.doi.org/10.1038/mtm.2014.30

Ejemplares similares

Reprogrammed CD4(+) T Cells That Express FoxP3(+) Control Inhibitory Antibody Formation in Hemophilia A Mice
por: Herzog, Roland W., et al.
Publicado: (2019)

Treg: tolerance vs immunity
por: Biswas, Moanaro, et al.
Publicado: (2015)

Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B
por: Nayak, Sushrusha, et al.
Publicado: (2011)

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017)

Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
por: Martino, Ashley T., et al.
Publicado: (2009)

Gene Therapy With Regulatory T Cells: A Beneficial Alliance
por: Biswas, Moanaro, et al.
Publicado: (2018)

Clinical development of gene therapy: results and lessons from recent successes
por: Kumar, Sandeep RP, et al.
Publicado: (2016)

Dynamics of antigen presentation to transgene product-specific CD4(+) T cells and of Treg induction upon hepatic AAV gene transfer
por: Perrin, George Q, et al.
Publicado: (2016)

Development of gene transfer for induction of antigen-specific tolerance
por: Sack, Brandon K, et al.
Publicado: (2014)

Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells
por: Wang, Xiaomei, et al.
Publicado: (2017)

B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin
por: Biswas, Moanaro, et al.
Publicado: (2020)

Role of Small Intestine and Gut Microbiome in Plant-Based Oral Tolerance for Hemophilia
por: Kumar, Sandeep R. P., et al.
Publicado: (2020)

CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII
por: Rana, Jyoti, et al.
Publicado: (2021)

Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors
Publicado: (1979)

B cell–activating factor modulates the factor VIII immune response in hemophilia A
por: Doshi, Bhavya S., et al.
Publicado: (2021)

Gene Therapy Research at the Frontiers of Viral Immunology
por: Hoffman, Brad E., et al.
Publicado: (2012)

Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
por: Shapiro, Roman M., et al.
Publicado: (2022)

Responses to Microbial Challenges by SLAMF Receptors
por: van Driel, Boaz Job, et al.
Publicado: (2016)

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies
por: Markusic, David M, et al.
Publicado: (2013)

Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016)

Distinct functions and transcriptional signatures in orally induced regulatory T cell populations
por: Biswas, Moanaro, et al.
Publicado: (2023)

Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells
por: Liao, Gongxian, et al.
Publicado: (2014)

Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells
por: Vahedi, Fatemeh, et al.
Publicado: (2017)

T Cell Receptor Profiling in Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2017)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
por: Polito, Vinicia A., et al.
Publicado: (2019)

Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
por: Liem, Nguyen Thanh, et al.
Publicado: (2019)

The Need for Gene Therapy for the Effective Treatment of Hemophilia
por: Wynn, Tung, et al.
Publicado: (2012)

Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX
por: Ramaswamy, Suvasini, et al.
Publicado: (2018)

The novel polyclonal Ab preparation trimodulin attenuates ex vivo endotoxin-induced immune reactions in early hyperinflammation
por: Duerr, Celia, et al.
Publicado: (2019)

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce
por: Herzog, Roland W., et al.
Publicado: (2017)

Post Autologous Bone Marrow Transplant Associated With a Resultant Mixed Polyclonal/Monoclonal Hyper-IgG3
por: Fill, Lauren, et al.
Publicado: (2020)

A pilot study on ex vivo expanded autologous adipose‐derived stem cells of improving fat retention in localized scleroderma patients
por: Wang, Chenyu, et al.
Publicado: (2021)

Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
por: Arjomandnejad, Motahareh, et al.
Publicado: (2021)

Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice
por: Kwon, Kwang‐Chul, et al.
Publicado: (2017)

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma
por: Ozaki, Shuji, et al.
Publicado: (2019)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with (89)Zr-oxine for Medium-Term In Vivo Cell Tracking
por: Jacob, Jacinta, et al.
Publicado: (2023)

Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A
por: Stem, Christopher, et al.
Publicado: (2021)

Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy
por: Seay, Howard R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_psgcstm0cb2h3f04ru9u1ooi7r